APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiac Stent

A Cardiac Stent (also called coronary stent) is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A Cardiac Stent (also called coronary stent) is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI).

Selected research

Market Structure

Global Cardiac Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025197 pages

Choose your research edition.

Industry ResearchCardiac Stent Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac Stent Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Cardiac Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac Stent Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac Stent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

A Cardiac Stent (also called coronary stent) is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI).

The global PCI device market is projected to gain growth on the back of the prevalence of cardiovascular diseases and the aging process. The global Cardiac Stent market is forecasted to keep the trend.

As the technology of Cardiac Stent is relatively mature and the downstream market, especially for Angina application is growing fast, so there are lots of enterprises in the Cardiac Stent market. The Cardiac Stent market competition will be still intense. Abbott Vascular is the leading manufacturer in the global Cardiac Stent market with the market share of 24.95%, in terms of revenue, followed by Boston Scientific, Medtronic, Terumo (ESSEN), Lepu Medical, MicroPort, Biosensors, B.Braun, Atrium Medical, Biotronik, and SINOMED. These leading 11 companies accounted for 96% of the market share in 2019.

Read the full market overview

This report provides an overview of the global Cardiac Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiac Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cardiac Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiac Stent market size, projected growth trends, production technologies, key applications, and end-use industries.

Cardiac Stent Segment by Company

Abbott Vascular

Boston Scientific

Medtronic

Terumo (ESSEN)

Lepu Medical

MicroPort

Biosensors

B.Braun

Atrium Medical

Biotronik

SINOMED

Cardiac Stent Segment by Type

Bare-metal Stent (BMS)

Drug-eluting Stent (DES)

Bioresorbable Vascular Scaffold (BVS)

Cardiac Stent Segment by Application

Angina

Myocardial Infarction

Other Disease

Cardiac Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cardiac Stent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cardiac Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cardiac Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cardiac Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cardiac Stent Industry Trends Table 2. Cardiac Stent Industry Drivers Table 3. Cardiac Stent Industry Opportunities and Challenges Table 4. Cardiac Stent Industry Restraints Table 5. Global Cardiac Stent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cardiac Stent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cardiac Stent Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cardiac Stent Sales Market Share by Manufacturers Table 9. Global Cardiac Stent Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cardiac Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cardiac Stent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cardiac Stent Manufacturers, Product Type & Application Table 13. Global Cardiac Stent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cardiac Stent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Bare-metal Stent (BMS) Table 17. Major Manufacturers of Drug-eluting Stent (DES) Table 18. Major Manufacturers of Bioresorbable Vascular Scaffold (BVS) Table 19. Global Cardiac Stent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Cardiac Stent Sales by Type (2021-2026) & (K Units) Table 21. Global Cardiac Stent Sales by Type (2027-2032) & (K Units) Table 22. Global Cardiac Stent Sales Market Share by Type (2021-2026) Table 23. Global Cardiac Stent Sales Market Share by Type (2027-2032) Table 24. Global Cardiac Stent Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Cardiac Stent Revenue by Type (2021-2026) & (K Units) Table 26. Global Cardiac Stent Revenue by Type (2027-2032) & (K Units) Table 27. Global Cardiac Stent Revenue Market Share by Type (2021-2026) Table 28. Global Cardiac Stent Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Angina Table 30. Major Manufacturers of Myocardial Infarction Table 31. Major Manufacturers of Other Disease Table 32. Global Cardiac Stent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Cardiac Stent Sales by Application (2021-2026) & (K Units) Table 34. Global Cardiac Stent Sales by Application (2027-2032) & (K Units) Table 35. Global Cardiac Stent Sales Market Share by Application (2021-2026) Table 36. Global Cardiac Stent Sales Market Share by Application (2027-2032) Table 37. Global Cardiac Stent Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Cardiac Stent Revenue by Application (2021-2026) & (K Units) Table 39. Global Cardiac Stent Revenue by Application (2027-2032) & (K Units) Table 40. Global Cardiac Stent Revenue Market Share by Application (2021-2026) Table 41. Global Cardiac Stent Revenue Market Share by Application (2027-2032) Table 42. Global Cardiac Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Cardiac Stent Sales by Region (2021-2026) & (K Units) Table 44. Global Cardiac Stent Sales Market Share by Region (2021-2026) Table 45. Global Cardiac Stent Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Cardiac Stent Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Cardiac Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Cardiac Stent Sales by Country (2021-2026) & (K Units) Table 49. North America Cardiac Stent Sales by Country (2027-2032) & (K Units) Table 50. Europe Cardiac Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Cardiac Stent Sales by Country (2021-2026) & (K Units) Table 52. Europe Cardiac Stent Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Cardiac Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Cardiac Stent Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Cardiac Stent Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Cardiac Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Cardiac Stent Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Cardiac Stent Sales by Country (2027-2032) & (K Units) Table 59. Global Cardiac Stent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Cardiac Stent Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Cardiac Stent Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Cardiac Stent Revenue Market Share by Region (2021-2026) Table 63. Global Cardiac Stent Revenue Market Share by Region (2027-2032) Table 64. Abbott Vascular Company Information Table 65. Abbott Vascular Business Overview Table 66. Abbott Vascular Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Vascular Cardiac Stent Product Portfolio Table 68. Abbott Vascular Recent Development Table 69. Boston Scientific Company Information Table 70. Boston Scientific Business Overview Table 71. Boston Scientific Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Boston Scientific Cardiac Stent Product Portfolio Table 73. Boston Scientific Recent Development Table 74. Medtronic Company Information Table 75. Medtronic Business Overview Table 76. Medtronic Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Medtronic Cardiac Stent Product Portfolio Table 78. Medtronic Recent Development Table 79. Terumo (ESSEN) Company Information Table 80. Terumo (ESSEN) Business Overview Table 81. Terumo (ESSEN) Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Terumo (ESSEN) Cardiac Stent Product Portfolio Table 83. Terumo (ESSEN) Recent Development Table 84. Lepu Medical Company Information Table 85. Lepu Medical Business Overview Table 86. Lepu Medical Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Lepu Medical Cardiac Stent Product Portfolio Table 88. Lepu Medical Recent Development Table 89. MicroPort Company Information Table 90. MicroPort Business Overview Table 91. MicroPort Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. MicroPort Cardiac Stent Product Portfolio Table 93. MicroPort Recent Development Table 94. Biosensors Company Information Table 95. Biosensors Business Overview Table 96. Biosensors Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Biosensors Cardiac Stent Product Portfolio Table 98. Biosensors Recent Development Table 99. B.Braun Company Information Table 100. B.Braun Business Overview Table 101. B.Braun Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. B.Braun Cardiac Stent Product Portfolio Table 103. B.Braun Recent Development Table 104. Atrium Medical Company Information Table 105. Atrium Medical Business Overview Table 106. Atrium Medical Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Atrium Medical Cardiac Stent Product Portfolio Table 108. Atrium Medical Recent Development Table 109. Biotronik Company Information Table 110. Biotronik Business Overview Table 111. Biotronik Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Biotronik Cardiac Stent Product Portfolio Table 113. Biotronik Recent Development Table 114. SINOMED Company Information Table 115. SINOMED Business Overview Table 116. SINOMED Cardiac Stent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. SINOMED Cardiac Stent Product Portfolio Table 118. SINOMED Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Cardiac Stent Distributors List Table 122. Cardiac Stent Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Cardiac Stent Product Image Figure 2. Global Cardiac Stent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiac Stent Market Size (2021-2032) & (US$ Million) Figure 4. Global Cardiac Stent Sales (2021-2032) & (K Units) Figure 5. Global Cardiac Stent Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cardiac Stent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Bare-metal Stent (BMS) Image Figure 9. Drug-eluting Stent (DES) Image Figure 10. Bioresorbable Vascular Scaffold (BVS) Image Figure 11. Global Cardiac Stent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Cardiac Stent Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Cardiac Stent Sales Market Share by Type (2021-2032) Figure 14. Global Cardiac Stent Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Cardiac Stent Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Cardiac Stent Revenue Market Share by Type (2021-2032) Figure 17. Angina Image Figure 18. Myocardial Infarction Image Figure 19. Other Disease Image Figure 20. Global Cardiac Stent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Cardiac Stent Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Cardiac Stent Sales Market Share by Application (2021-2032) Figure 23. Global Cardiac Stent Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Cardiac Stent Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Cardiac Stent Revenue Market Share by Application (2021-2032) Figure 26. North America Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Cardiac Stent Sales Market Share by Country (2021-2032) Figure 28. U.S. Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Cardiac Stent Sales Market Share by Country (2021-2032) Figure 33. Germany Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Cardiac Stent Sales Market Share by Country (2021-2032) Figure 40. China Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Cardiac Stent Sales Market Share by Country (2021-2032) Figure 48. Brazil Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Cardiac Stent Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Cardiac Stent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Cardiac Stent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Cardiac Stent Revenue (2021-2032) & (US$ Million) Figure 59. North America Cardiac Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Cardiac Stent Revenue (2021-2032) & (US$ Million) Figure 61. Europe Cardiac Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Cardiac Stent Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Cardiac Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Cardiac Stent Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Cardiac Stent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Cardiac Stent Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Cardiac Stent Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Bare-metal Stent (BMS)
  • Drug-eluting Stent (DES)
  • Bioresorbable Vascular Scaffold (BVS)
Applications
  • Angina
  • Myocardial Infarction
  • Other Disease
Companies covered
  • Abbott Vascular
  • Boston Scientific
  • Medtronic
  • Terumo (ESSEN)
  • Lepu Medical
  • MicroPort
  • Biosensors
  • B.Braun
  • Atrium Medical
  • Biotronik
  • SINOMED

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cardiac Stent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cardiac Stent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cardiac Stent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cardiac Stent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cardiac Stent Market Dynamics
  1. 2.1 Cardiac Stent Industry Trends
  2. 2.2 Cardiac Stent Industry Drivers
  3. 2.3 Cardiac Stent Industry Opportunities and Challenges
  4. 2.4 Cardiac Stent Industry Restraints
3 Cardiac Stent Market by Manufacturers
  1. 3.1 Global Cardiac Stent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cardiac Stent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cardiac Stent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cardiac Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cardiac Stent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cardiac Stent Manufacturers, Product Type & Application
  7. 3.7 Global Cardiac Stent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cardiac Stent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cardiac Stent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cardiac Stent Tier 1, Tier 2, and Tier 3
4 Cardiac Stent Market by Type
  1. 4.1 Cardiac Stent Type Introduction
  2. 4.1.1 Bare-metal Stent (BMS)
  3. 4.1.2 Drug-eluting Stent (DES)
  4. 4.1.3 Bioresorbable Vascular Scaffold (BVS)
  5. 4.2 Global Cardiac Stent Sales by Type
  6. 4.2.1 Global Cardiac Stent Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cardiac Stent Sales by Type (2021-2032)
  8. 4.2.3 Global Cardiac Stent Sales Market Share by Type (2021-2032)
  9. 4.3 Global Cardiac Stent Revenue by Type
  10. 4.3.1 Global Cardiac Stent Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Cardiac Stent Revenue by Type (2021-2032)
  12. 4.3.3 Global Cardiac Stent Revenue Market Share by Type (2021-2032)
5 Cardiac Stent Market by Application
  1. 5.1 Cardiac Stent Application Introduction
  2. 5.1.1 Angina
  3. 5.1.2 Myocardial Infarction
  4. 5.1.3 Other Disease
  5. 5.2 Global Cardiac Stent Sales by Application
  6. 5.2.1 Global Cardiac Stent Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cardiac Stent Sales by Application (2021-2032)
  8. 5.2.3 Global Cardiac Stent Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cardiac Stent Revenue by Application
  10. 5.3.1 Global Cardiac Stent Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cardiac Stent Revenue by Application (2021-2032)
  12. 5.3.3 Global Cardiac Stent Revenue Market Share by Application (2021-2032)
6 Global Cardiac Stent Sales by Region
  1. 6.1 Global Cardiac Stent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cardiac Stent Sales by Region (2021-2032)
  3. 6.2.1 Global Cardiac Stent Sales by Region (2021-2026)
  4. 6.2.2 Global Cardiac Stent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cardiac Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cardiac Stent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cardiac Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cardiac Stent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cardiac Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cardiac Stent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cardiac Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cardiac Stent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cardiac Stent Revenue by Region
  1. 7.1 Global Cardiac Stent Revenue by Region
  2. 7.1.1 Global Cardiac Stent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cardiac Stent Revenue by Region (2021-2026)
  4. 7.1.3 Global Cardiac Stent Revenue by Region (2027-2032)
  5. 7.1.4 Global Cardiac Stent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cardiac Stent Revenue (2021-2032)
  8. 7.2.2 North America Cardiac Stent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cardiac Stent Revenue (2021-2032)
  11. 7.3.2 Europe Cardiac Stent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cardiac Stent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cardiac Stent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cardiac Stent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cardiac Stent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Vascular
  2. 8.1.1 Abbott Vascular Company Information
  3. 8.1.2 Abbott Vascular Business Overview
  4. 8.1.3 Abbott Vascular Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Vascular Cardiac Stent Product Portfolio
  6. 8.1.5 Abbott Vascular Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Cardiac Stent Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Cardiac Stent Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Terumo (ESSEN)
  20. 8.4.1 Terumo (ESSEN) Company Information
  21. 8.4.2 Terumo (ESSEN) Business Overview
  22. 8.4.3 Terumo (ESSEN) Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Terumo (ESSEN) Cardiac Stent Product Portfolio
  24. 8.4.5 Terumo (ESSEN) Recent Developments
  25. 8.5 Lepu Medical
  26. 8.5.1 Lepu Medical Company Information
  27. 8.5.2 Lepu Medical Business Overview
  28. 8.5.3 Lepu Medical Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lepu Medical Cardiac Stent Product Portfolio
  30. 8.5.5 Lepu Medical Recent Developments
  31. 8.6 MicroPort
  32. 8.6.1 MicroPort Company Information
  33. 8.6.2 MicroPort Business Overview
  34. 8.6.3 MicroPort Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MicroPort Cardiac Stent Product Portfolio
  36. 8.6.5 MicroPort Recent Developments
  37. 8.7 Biosensors
  38. 8.7.1 Biosensors Company Information
  39. 8.7.2 Biosensors Business Overview
  40. 8.7.3 Biosensors Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biosensors Cardiac Stent Product Portfolio
  42. 8.7.5 Biosensors Recent Developments
  43. 8.8 B.Braun
  44. 8.8.1 B.Braun Company Information
  45. 8.8.2 B.Braun Business Overview
  46. 8.8.3 B.Braun Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 B.Braun Cardiac Stent Product Portfolio
  48. 8.8.5 B.Braun Recent Developments
  49. 8.9 Atrium Medical
  50. 8.9.1 Atrium Medical Company Information
  51. 8.9.2 Atrium Medical Business Overview
  52. 8.9.3 Atrium Medical Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Atrium Medical Cardiac Stent Product Portfolio
  54. 8.9.5 Atrium Medical Recent Developments
  55. 8.10 Biotronik
  56. 8.10.1 Biotronik Company Information
  57. 8.10.2 Biotronik Business Overview
  58. 8.10.3 Biotronik Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biotronik Cardiac Stent Product Portfolio
  60. 8.10.5 Biotronik Recent Developments
  61. 8.11 SINOMED
  62. 8.11.1 SINOMED Company Information
  63. 8.11.2 SINOMED Business Overview
  64. 8.11.3 SINOMED Cardiac Stent Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 SINOMED Cardiac Stent Product Portfolio
  66. 8.11.5 SINOMED Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cardiac Stent Value Chain Analysis
  2. 9.1.1 Cardiac Stent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cardiac Stent Production Mode & Process
  6. 9.2 Cardiac Stent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cardiac Stent Distributors
  9. 9.2.3 Cardiac Stent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst